Free Trial
→ The $15 Gold Fund That Pays Up to $1,152/Month (From Investors Alley) (Ad)tc pixel
NYSE:ALC

Alcon Q3 2026 Earnings Date & Estimates

Alcon logo
$66.58 +2.72 (+4.25%)
As of 02:15 PM Eastern
This is a fair market value price provided by Massive. Learn more.

Alcon is estimated to report Q3 2026 earnings on Tuesday, November 10, 2026, after market closes. The conference call is scheduled for November 11, 2026 at 8:00 AM ET.

Research:ProfileEarnings HistoryForecast

Upcoming Earnings Announcement

Quarter
Q3 2026
Announcement Date
Time
After Market Closes
Conference Call Date
Conference Call
8:00 AM ET
Google Calendar (opens in a new tab)Outlook (opens in a new tab)Yahoo Calendar (opens in a new tab)

What Analysts Expect from Alcon in Q3 2026

Alcon is expected to post earnings of $0.89 per share on revenue of $2.68 billion. In the same quarter a year earlier Alcon reported $0.79 per share on revenue of $2.59 billion. Alcon last reported on August 10, 2026, posting $0.84 per share and beating the $0.77 consensus estimate. Alcon has beaten the consensus EPS estimate in 6 of its last 8 quarters.

Consensus Estimates

Consensus EPS
$0.89
Expected Revenue
$2.68 billion
Prior-Year EPS
$0.79
Prior-Year Revenue
$2.59 billion
Expected EPS Growth
+12.7%
Expected Revenue Growth
+3.6%

Recent Track Record

Last Reported
Q2 2026
Last Quarter EPS
$0.84 (Beat by +$0.07)
Last Quarter Revenue
$2.82 billion
EPS Beat Rate
6 of last 8 quarters

Prepare for the Q3 2026 Call

Alcon Q3 2026 Earnings FAQ

Alcon (NYSE:ALC) is estimated to report Q3 2026 earnings on Tuesday, November 10, 2026, after market closes. This date is estimated from past reporting schedules and may change once the company confirms it.

Alcon's Q3 2026 earnings conference call is scheduled for Wednesday, November 11, 2026 at 8:00 AM ET. MarketBeat streams the conference call audio and posts the transcript as soon as possible on the earnings announcement date.

Analysts expect Alcon to post earnings of $0.89 per share for Q3 2026.

The consensus revenue estimate for Alcon is $2.68 billion for Q3 2026.

Alcon Earnings Headlines

Alcon introduces PanOptix Pro intraocular lens in India
October 13 at 9:32 AM  |  health.economictimes.indiatimes.comhttps://health.economictimes.indiatimes.com/news/medical-devices/alcon-introduces-panoptix-pro-intraocular-lens-in-india/134917932
Alcon unveils Clareon PanOptix Pro in India to expand advanced cataract surgery portfolio
October 8, 2026  |  msn.comhttps://www.msn.com/en-in/news/other/alcon-unveils-clareon-panoptix-pro-in-india-to-expand-advanced-cataract-surgery-portfolio/ar-AA2dQkND
Ready to give options a try? Your first trade (Ticker included) -INSIDE
Tired of trying tactic after tactic when it comes to options trades... only to be met with market noise and stinging losses? Dave Aquino is giving away the exact 11-hour options strategy he uses in volatile markets. You get the plain English blueprint behind the strategy and the very same "rinse and repeat" ticker he's traded nearly 900 times with a 95.3% success rate. It's so simple to understand, you could trade it tomorrow.tc pixel
October 15 at 1:00 AM  |  Base Camp Trading (Ad)
Alcon : Highlights Its Comprehensive Innovation Portfolio at AAO 2026
October 6, 2026  |  marketscreener.comM
Alcon: Underperform Rating Reiterated as Analyst Flags Mounting Headwinds; $48 Price Target Maintained
October 6, 2026  |  tipranks.comhttps://www.tipranks.com/news/ratings/alcon-underperform-rating-reiterated-as-analyst-flags-mounting-headwinds-48-price-target-maintained-ratings-news?utm_source=marketbeat.com&utm_medium=referral
Denis Villeneuve’s Crime Movie With Hugh Jackman & Jake Gyllenhaal Is Getting a TV Show Reboot
October 5, 2026  |  yahoo.comhttps://www.yahoo.com/entertainment/tv/articles/denis-villeneuve-crime-movie-hugh-195944442.html
See More Alcon Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Alcon? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Alcon and other key companies, straight to your email.

About Alcon

Alcon (NYSE:ALC) Inc. (NYSE: ALC) is a global eye care company that develops, manufactures and markets products for eye care professionals and consumers. Its business is organized primarily around Surgical and Vision Care, serving ophthalmologists, optometrists, surgeons and patients worldwide.

The company’s Surgical portfolio includes equipment, instruments, implantable products and other technologies used in cataract, retinal, refractive and other ophthalmic procedures. Its Vision Care business offers contact lenses, contact lens care products and over-the-counter eye care products designed to support vision correction and ocular health.

Alcon traces its origins to an ophthalmic business founded in Fort Worth, Texas, in 1945. It later became part of Novartis before being spun off as an independent, publicly traded company in 2019. Alcon serves customers in numerous markets across the Americas, Europe, Asia and other regions, and is led by Chief Executive Officer David J. Endicott.

View Alcon Profile
Earnings Tools